Corporate News     03-Sep-22
Board of Suven Pharmaceuticals recommends interim dividend
Of Rs 1 per share
Suven Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 2 September 2022, inter alia, have recommended the interim dividend of Rs 1 per equity Share (i.e. 100%) , subject to the approval of the shareholders.
Previous News
  Suven Pharmaceuticals consolidated net profit rises 14.82% in the June 2021 quarter
 ( Results - Announcements 13-Aug-21   14:42 )
  Suven Pharmaceuticals postpones board meeting
 ( Corporate News - 22-May-24   14:26 )
  Suven Pharma slips after Q2 earnings
 ( Hot Pursuit - 08-Nov-21   10:32 )
  Suven Pharmaceuticals Ltd Surges 11.39%, S&P BSE Healthcare index Gains 1.86%
 ( Hot Pursuit - 22-Jun-20   09:30 )
  Suven Pharmaceuticals to table results
 ( Corporate News - 22-May-23   12:59 )
  Board of Suven Pharmaceuticals approves acquisition of Casper Pharma
 ( Corporate News - 05-Apr-22   13:18 )
  Suven Pharmaceuticals consolidated net profit declines 56.95% in the March 2024 quarter
 ( Results - Announcements 31-May-24   07:40 )
  Suven Pharmaceuticals consolidated net profit rises 35.24% in the March 2023 quarter
 ( Results - Announcements 25-May-23   14:41 )
  Volumes soar at Relaxo Footwears Ltd counter
 ( Hot Pursuit - 26-Dec-22   14:30 )
  Board of Suven Pharmaceuticals appoints director
 ( Corporate News - 23-Jul-21   15:49 )
  Suven Pharma approves acquisition of Casper Pharma
 ( Hot Pursuit - 05-Apr-22   16:24 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top